MHC Class II Regulation — Lessons from a Disease
- 12 January 1995
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (2) , 120-123
- https://doi.org/10.1056/nejm199501123320211
Abstract
Elucidating the molecular and genetic basis of a hereditary disease often has implications that go beyond the understanding of the disease itself and that may concern important biologic processes. When it was shown that a form of primary immunodeficiency, major histocompatibility complex (MHC) class II deficiency (also referred to as the bare lymphocyte syndrome), was in fact a disease of gene regulation involving trans-acting regulatory factors,1 there was hope that elucidating the genetic basis of that rare disease might lead to the identification of the essential regulators of MHC class II gene expression. MHC class II genes, originally described . . .Keywords
This publication has 9 references indexed in Scilit:
- Twin Boys with Major Histocompatibility Complex Class II Deficiency but Inducible Immune ResponsesNew England Journal of Medicine, 1995
- Absence of MHC class ii molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophyCell, 1994
- Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITAScience, 1994
- Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.Proceedings of the National Academy of Sciences, 1994
- Sequences and Factors: A Guide to MHC Class-II TranscriptionAnnual Review of Immunology, 1992
- Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis.Proceedings of the National Academy of Sciences, 1991
- Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factorsHuman Immunology, 1989
- Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-XCell, 1988
- A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genesNature, 1985